The Food and Drug Administration issued a warning in June 2011 that diabetic patients who have taken Actos and other pioglitazone-containing medicines are at a higher risk of developing bladder cancer. The warning notes that the risk is higher in patients who have taken higher dosages of Actos for more than 12 months.
France has stopped the release of these drugs. The FDA noted that it was aware of France’s decision. However, the FDA has not banned these medicines from being issued in the United States.
Gersowitz Libo & Korek, P.C. has been researching patients who have developed bladder cancer as a result of taking Actos and is now accepting new clients. If you or a loved one has fallen victim to the drug Actos, contact Gersowitz Libo & Korek, P.C. at (800) 529-9997 to learn your legal rights.
Woman Falls From Moving SUV on the BQE Near the Brooklyn Bridge and Is Struck…
Deer Park EMT Critically Hurt After Pulling Over to Help at a Crash on the…
Ridge Woman Struck by Pickup Truck and Killed on Ronkonkoma Avenue Near Portion Road on…
Scaffolding Gives Way Beneath Eight Workers on the Loop Parkway Drawbridge, Leaving One Dead and…
Left-Turning SUV Strikes a 74-Year-Old Man at Chatham Square, One of Chinatown's Most Complicated Intersections…
Fire Officials Say a Charging E-Bike Left a Family No Safe Way Out of Their…